Global Cancer Treatment Drugs Sales Market Report 2018

がん治療薬の世界市場:販売動向2018

◆タイトル:Global Cancer Treatment Drugs Sales Market Report 2018
◆商品コード:QYR80702920
◆調査・発行会社:QYResearch
◆発行日:2018年10月
◆ページ数:120
◆レポート形式:(印刷可能)PDF / 英語
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル、世界主要国(日本、アメリカ、中国、ヨーロッパ等)
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,000 ⇒換算¥452,000見積依頼/購入/質問フォーム
Enterprise(同一法人内共有可)USD8,000 ⇒換算¥904,000見積依頼/購入/質問フォーム
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常2日~3日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearchの日本における正規販売代理店です。

【レポートの概要】

本調査レポートでは、がん治療薬の世界市場について調査・分析し、がん治療薬のメーカー別販売量、市場シェア分析、種類別販売分析(化学療法、標的療法、免疫療法、ホルモン療法(生物療法)、その他)、用途別販売分析(血液がん、乳がん、胃腸がん、前立腺がん、呼吸器系がん・肺がん、その他)、地域別販売分析(米国、中国、欧州、日本、東南アジア、インド)、価格動向、企業動向、がん治療薬産業チェーン分析、世界市場規模予測などを含め、以下の構成でお届けいたします。

・がん治療薬市場概要
・がん治療薬のメーカー別販売量・メーカー別シェア
・がん治療薬の世界市場:種類別販売量(化学療法、標的療法、免疫療法、ホルモン療法(生物療法)、その他)
・がん治療薬の世界市場:用途別販売量(血液がん、乳がん、胃腸がん、前立腺がん、呼吸器系がん・肺がん、その他)
・がん治療薬の世界市場:地域別販売量・市場シェア
・がん治療薬の米国市場規模
・がん治療薬の中国市場規模
・がん治療薬の欧州市場規模
・がん治療薬の日本市場規模
・がん治療薬の東南アジア市場規模
・がん治療薬のインド市場規模
・がん治療薬のメーカー別分析(企業概要、事業概要、製品概要、収益、価格等)
・がん治療薬のコスト分析・価格動向
・がん治療薬の産業チェーン(サプライチェーン分析)
・がん治療薬のマーケティング戦略・販売チャネル、流通業者
・がん治療薬市場への影響要因分析
・がん治療薬の世界市場予測
・がん治療薬の米国市場予測
・がん治療薬の中国市場予測
・がん治療薬の欧州市場予測
・がん治療薬の日本市場予測
・がん治療薬の東南アジア市場予測
・がん治療薬のインド市場予測
・がん治療薬の種類別世界市場予測(化学療法、標的療法、免疫療法、ホルモン療法(生物療法)、その他)
・がん治療薬の用途別世界市場予測(血液がん、乳がん、胃腸がん、前立腺がん、呼吸器系がん・肺がん、その他)
...

This report studies the global Cancer Treatment Drugs market status and forecast, categorizes the global Cancer Treatment Drugs market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America).
Cancer Treatment Drugs are used to treat malignancies, or cancerous growths. Depending on the technology it cans classification into Chemotherapy, Targeted Therapy, Immunotherapy (Biologic Therapy), Hormonal Therapy and Others.
The classification of cancer treatment drugs includes chemotherapy, targeted therapy, immunotherapy, hormonal therapy and others, and the revenue proportion of chemotherapy in 2016 is about 51%.
Cancer treatment drugs are widely used for blood cancer, breast cancer, gastrointestinal cancer, prostate cancer, respiratory/lung cancer and other cancers. Amongst these different cancer types, blood cancer was the largest revenue generating segment in 2016, and the revenue market share is about 22%. The growth of blood cancer segment is majorly due to the high cost of the drugs used to treat blood cancer.
Europe region is the largest supplier of cancer treatment drugs, with a revenue market share nearly 47% in 2016. North America is the second largest supplier of cancer treatment drugs, enjoying revenue market share nearly 34% in 2016. Japan region is also holding the monopoly position around the world.
North America is the largest consumption place, with the consumption market share nearly 43% in 2016, and North America market size reached 46 billion USD. China, India and Southeast Asia are the emerging markets, and enjoy higher grow rate.
The global Cancer Treatment Drugs market is valued at xx million US$ in 2017 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2018-2025.

The major players covered in this report
Roche
Novartis
Celgene
Bristol-Myers Squibb
Amgen
Johnson & Johnson
Pfizer
Takeda
Eli Lilly
AstraZeneca
Astellas
Merck & Co.
Sanofi
Bayer
Biogen Idec
Eisai
Teva
Otsuka
Merck KGaA
Ipsen
AbbVie
Gilead Sciences

Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering
United States
Europe
China
Japan
Southeast Asia
India

We can also provide the customized separate regional or country-level reports, for the following regions:
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Rest of Asia-Pacific
Europe
Germany
France
UK
Italy
Spain
Russia
Rest of Europe
Central & South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Saudi Arabia
Turkey
Rest of Middle East & Africa

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Chemotherapy
Targeted Therapy
Immunotherapy
Hormonal Therapy (Biologic Therapy)
Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
Blood Cancer
Breast Cancer
Gastrointestinal Cancer
Prostate Cancer
Respiratory/Lung Cancer
Other Cancers

The study objectives of this report are:
To analyze and study the global Cancer Treatment Drugs sales, value, status (2013-2017) and forecast (2018-2025);
To analyze the top players in North America, Europe, China, Japan, Southeast Asia and India, to study the sales, value and market share of top players in these regions.
Focuses on the key Cancer Treatment Drugs players, to study the sales, value, market share and development plans in future.
Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
To define, describe and forecast the market by type, application and region.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Cancer Treatment Drugs are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders
Cancer Treatment Drugs Manufacturers
Cancer Treatment Drugs Distributors/Traders/Wholesalers
Cancer Treatment Drugs Subcomponent Manufacturers
Industry Association
Downstream Vendors

Available Customizations
With the given market data, QYResearch offers customizations according to the company’s specific needs. The following customization options are available for the report:
Regional and country-level analysis of the Cancer Treatment Drugs market, by end-use.
Detailed analysis and profiles of additional market players.

【レポートの目次】

Table of Contents

Global Cancer Treatment Drugs Sales Market Report 2018
1 Cancer Treatment Drugs Market Overview
1.1 Product Overview and Scope of Cancer Treatment Drugs
1.2 Classification of Cancer Treatment Drugs by Product Category
1.2.1 Global Cancer Treatment Drugs Market Size (Sales) Comparison by Type (2013-2025)
1.2.2 Global Cancer Treatment Drugs Market Size (Sales) Market Share by Type (Product Category) in 2017
1.2.3 Chemotherapy
1.2.4 Targeted Therapy
1.2.5 Immunotherapy
1.2.6 Hormonal Therapy (Biologic Therapy)
1.2.7 Others
1.3 Global Cancer Treatment Drugs Market by Application/End Users
1.3.1 Global Cancer Treatment Drugs Sales (Volume) and Market Share Comparison by Application (2013-2025)
1.3.1 Blood Cancer
1.3.2 Breast Cancer
1.3.3 Gastrointestinal Cancer
1.3.4 Prostate Cancer
1.3.5 Respiratory/Lung Cancer
1.3.6 Other Cancers
1.4 Global Cancer Treatment Drugs Market by Region
1.4.1 Global Cancer Treatment Drugs Market Size (Value) Comparison by Region (2013-2025)
1.4.2 United States Cancer Treatment Drugs Status and Prospect (2013-2025)
1.4.3 Europe Cancer Treatment Drugs Status and Prospect (2013-2025)
1.4.4 China Cancer Treatment Drugs Status and Prospect (2013-2025)
1.4.5 Japan Cancer Treatment Drugs Status and Prospect (2013-2025)
1.4.6 Southeast Asia Cancer Treatment Drugs Status and Prospect (2013-2025)
1.4.7 India Cancer Treatment Drugs Status and Prospect (2013-2025)
1.5 Global Market Size (Value and Volume) of Cancer Treatment Drugs (2013-2025)
1.5.1 Global Cancer Treatment Drugs Sales and Growth Rate (2013-2025)
1.5.2 Global Cancer Treatment Drugs Revenue and Growth Rate (2013-2025)

2 Global Cancer Treatment Drugs Competition by Players/Suppliers, Type and Application
2.1 Global Cancer Treatment Drugs Market Competition by Players/Suppliers
2.1.1 Global Cancer Treatment Drugs Sales and Market Share of Key Players/Suppliers (2013-2018)
2.1.2 Global Cancer Treatment Drugs Revenue and Share by Players/Suppliers (2013-2018)
2.2 Global Cancer Treatment Drugs (Volume and Value) by Type
2.2.1 Global Cancer Treatment Drugs Sales and Market Share by Type (2013-2018)
2.2.2 Global Cancer Treatment Drugs Revenue and Market Share by Type (2013-2018)
2.3 Global Cancer Treatment Drugs (Volume and Value) by Region
2.3.1 Global Cancer Treatment Drugs Sales and Market Share by Region (2013-2018)
2.3.2 Global Cancer Treatment Drugs Revenue and Market Share by Region (2013-2018)
2.4 Global Cancer Treatment Drugs (Volume) by Application

3 United States Cancer Treatment Drugs (Volume, Value and Sales Price)
3.1 United States Cancer Treatment Drugs Sales and Value (2013-2018)
3.1.1 United States Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
3.1.2 United States Cancer Treatment Drugs Revenue and Growth Rate (2013-2018)
3.1.3 United States Cancer Treatment Drugs Sales Price Trend (2013-2018)
3.2 United States Cancer Treatment Drugs Sales Volume and Market Share by Players (2013-2018)
3.3 United States Cancer Treatment Drugs Sales Volume and Market Share by Type (2013-2018)
3.4 United States Cancer Treatment Drugs Sales Volume and Market Share by Application (2013-2018)

4 Europe Cancer Treatment Drugs (Volume, Value and Sales Price)
4.1 Europe Cancer Treatment Drugs Sales and Value (2013-2018)
4.1.1 Europe Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
4.1.2 Europe Cancer Treatment Drugs Revenue and Growth Rate (2013-2018)
4.1.3 Europe Cancer Treatment Drugs Sales Price Trend (2013-2018)
4.2 Europe Cancer Treatment Drugs Sales Volume and Market Share by Players (2013-2018)
4.3 Europe Cancer Treatment Drugs Sales Volume and Market Share by Type (2013-2018)
4.4 Europe Cancer Treatment Drugs Sales Volume and Market Share by Application (2013-2018)

5 China Cancer Treatment Drugs (Volume, Value and Sales Price)
5.1 China Cancer Treatment Drugs Sales and Value (2013-2018)
5.1.1 China Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
5.1.2 China Cancer Treatment Drugs Revenue and Growth Rate (2013-2018)
5.1.3 China Cancer Treatment Drugs Sales Price Trend (2013-2018)
5.2 China Cancer Treatment Drugs Sales Volume and Market Share by Players (2013-2018)
5.3 China Cancer Treatment Drugs Sales Volume and Market Share by Type (2013-2018)
5.4 China Cancer Treatment Drugs Sales Volume and Market Share by Application (2013-2018)

6 Japan Cancer Treatment Drugs (Volume, Value and Sales Price)
6.1 Japan Cancer Treatment Drugs Sales and Value (2013-2018)
6.1.1 Japan Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
6.1.2 Japan Cancer Treatment Drugs Revenue and Growth Rate (2013-2018)
6.1.3 Japan Cancer Treatment Drugs Sales Price Trend (2013-2018)
6.2 Japan Cancer Treatment Drugs Sales Volume and Market Share by Players (2013-2018)
6.3 Japan Cancer Treatment Drugs Sales Volume and Market Share by Type (2013-2018)
6.4 Japan Cancer Treatment Drugs Sales Volume and Market Share by Application (2013-2018)

7 Southeast Asia Cancer Treatment Drugs (Volume, Value and Sales Price)
7.1 Southeast Asia Cancer Treatment Drugs Sales and Value (2013-2018)
7.1.1 Southeast Asia Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
7.1.2 Southeast Asia Cancer Treatment Drugs Revenue and Growth Rate (2013-2018)
7.1.3 Southeast Asia Cancer Treatment Drugs Sales Price Trend (2013-2018)
7.2 Southeast Asia Cancer Treatment Drugs Sales Volume and Market Share by Players (2013-2018)
7.3 Southeast Asia Cancer Treatment Drugs Sales Volume and Market Share by Type (2013-2018)
7.4 Southeast Asia Cancer Treatment Drugs Sales Volume and Market Share by Application (2013-2018)

8 India Cancer Treatment Drugs (Volume, Value and Sales Price)
8.1 India Cancer Treatment Drugs Sales and Value (2013-2018)
8.1.1 India Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
8.1.2 India Cancer Treatment Drugs Revenue and Growth Rate (2013-2018)
8.1.3 India Cancer Treatment Drugs Sales Price Trend (2013-2018)
8.2 India Cancer Treatment Drugs Sales Volume and Market Share by Players (2013-2018)
8.3 India Cancer Treatment Drugs Sales Volume and Market Share by Type (2013-2018)
8.4 India Cancer Treatment Drugs Sales Volume and Market Share by Application (2013-2018)

9 Global Cancer Treatment Drugs Players/Suppliers Profiles and Sales Data
9.1 Roche
9.1.1 Company Basic Information, Manufacturing Base and Competitors
9.1.2 Cancer Treatment Drugs Product Category, Application and Specification
9.1.2.1 Product A
9.1.2.2 Product B
9.1.3 Roche Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
9.1.4 Main Business/Business Overview
9.2 Novartis
9.2.1 Company Basic Information, Manufacturing Base and Competitors
9.2.2 Cancer Treatment Drugs Product Category, Application and Specification
9.2.2.1 Product A
9.2.2.2 Product B
9.2.3 Novartis Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
9.2.4 Main Business/Business Overview
9.3 Celgene
9.3.1 Company Basic Information, Manufacturing Base and Competitors
9.3.2 Cancer Treatment Drugs Product Category, Application and Specification
9.3.2.1 Product A
9.3.2.2 Product B
9.3.3 Celgene Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
9.3.4 Main Business/Business Overview
9.4 Bristol-Myers Squibb
9.4.1 Company Basic Information, Manufacturing Base and Competitors
9.4.2 Cancer Treatment Drugs Product Category, Application and Specification
9.4.2.1 Product A
9.4.2.2 Product B
9.4.3 Bristol-Myers Squibb Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
9.4.4 Main Business/Business Overview
9.5 Amgen
9.5.1 Company Basic Information, Manufacturing Base and Competitors
9.5.2 Cancer Treatment Drugs Product Category, Application and Specification
9.5.2.1 Product A
9.5.2.2 Product B
9.5.3 Amgen Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
9.5.4 Main Business/Business Overview
9.6 Johnson & Johnson
9.6.1 Company Basic Information, Manufacturing Base and Competitors
9.6.2 Cancer Treatment Drugs Product Category, Application and Specification
9.6.2.1 Product A
9.6.2.2 Product B
9.6.3 Johnson & Johnson Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
9.6.4 Main Business/Business Overview
9.7 Pfizer
9.7.1 Company Basic Information, Manufacturing Base and Competitors
9.7.2 Cancer Treatment Drugs Product Category, Application and Specification
9.7.2.1 Product A
9.7.2.2 Product B
9.7.3 Pfizer Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
9.7.4 Main Business/Business Overview
9.8 Takeda
9.8.1 Company Basic Information, Manufacturing Base and Competitors
9.8.2 Cancer Treatment Drugs Product Category, Application and Specification
9.8.2.1 Product A
9.8.2.2 Product B
9.8.3 Takeda Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
9.8.4 Main Business/Business Overview
9.9 Eli Lilly
9.9.1 Company Basic Information, Manufacturing Base and Competitors
9.9.2 Cancer Treatment Drugs Product Category, Application and Specification
9.9.2.1 Product A
9.9.2.2 Product B
9.9.3 Eli Lilly Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
9.9.4 Main Business/Business Overview
9.10 AstraZeneca
9.10.1 Company Basic Information, Manufacturing Base and Competitors
9.10.2 Cancer Treatment Drugs Product Category, Application and Specification
9.10.2.1 Product A
9.10.2.2 Product B
9.10.3 AstraZeneca Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
9.10.4 Main Business/Business Overview
9.11 Astellas
9.12 Merck & Co.
9.13 Sanofi
9.14 Bayer
9.15 Biogen Idec
9.16 Eisai
9.17 Teva
9.18 Otsuka
9.19 Merck KGaA
9.20 Ipsen
9.21 AbbVie
9.22 Gilead Sciences

10 Cancer Treatment Drugs Maufacturing Cost Analysis
10.1 Cancer Treatment Drugs Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Price Trend of Key Raw Materials
10.1.3 Key Suppliers of Raw Materials
10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.2.1 Raw Materials
10.2.2 Labor Cost
10.2.3 Manufacturing Process Analysis of Cancer Treatment Drugs
10.3 Manufacturing Process Analysis of Cancer Treatment Drugs

11 Industrial Chain, Sourcing Strategy and Downstream Buyers
11.1 Cancer Treatment Drugs Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Cancer Treatment Drugs Major Manufacturers in 2017
11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List

13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes Threat
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 Global Cancer Treatment Drugs Market Forecast (2018-2025)
14.1 Global Cancer Treatment Drugs Sales Volume, Revenue and Price Forecast (2018-2025)
14.1.1 Global Cancer Treatment Drugs Sales Volume and Growth Rate Forecast (2018-2025)
14.1.2 Global Cancer Treatment Drugs Revenue and Growth Rate Forecast (2018-2025)
14.1.3 Global Cancer Treatment Drugs Price and Trend Forecast (2018-2025)
14.2 Global Cancer Treatment Drugs Sales Volume, Revenue and Growth Rate Forecast by Region (2018-2025)
14.2.1 Global Cancer Treatment Drugs Sales Volume and Growth Rate Forecast by Regions (2018-2025)
14.2.2 Global Cancer Treatment Drugs Revenue and Growth Rate Forecast by Regions (2018-2025)
14.2.3 United States Cancer Treatment Drugs Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.4 Europe Cancer Treatment Drugs Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.5 China Cancer Treatment Drugs Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.6 Japan Cancer Treatment Drugs Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.7 Southeast Asia Cancer Treatment Drugs Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.8 India Cancer Treatment Drugs Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.3 Global Cancer Treatment Drugs Sales Volume, Revenue and Price Forecast by Type (2018-2025)
14.3.1 Global Cancer Treatment Drugs Sales Forecast by Type (2018-2025)
14.3.2 Global Cancer Treatment Drugs Revenue Forecast by Type (2018-2025)
14.3.3 Global Cancer Treatment Drugs Price Forecast by Type (2018-2025)
14.4 Global Cancer Treatment Drugs Sales Volume Forecast by Application (2018-2025)

15 Research Findings and Conclusion

16 Appendix
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Disclaimer

List of Tables and Figures

Figure Product Picture of Cancer Treatment Drugs
Figure Global Cancer Treatment Drugs Sales Volume Comparison (K Units) by Type (2013-2025)
Figure Global Cancer Treatment Drugs Sales Volume Market Share by Type (Product Category) in 2017
Figure Chemotherapy Product Picture
Figure Targeted Therapy Product Picture
Figure Immunotherapy Product Picture
Figure Hormonal Therapy (Biologic Therapy) Product Picture
Figure Others Product Picture
Figure Global Cancer Treatment Drugs Sales Comparison (K Units) by Application (2013-2025)
Figure Global Sales Market Share of Cancer Treatment Drugs by Application in 2017
Figure Blood Cancer Examples
Table Key Downstream Customer in Blood Cancer
Figure Breast Cancer Examples
Table Key Downstream Customer in Breast Cancer
Figure Gastrointestinal Cancer Examples
Table Key Downstream Customer in Gastrointestinal Cancer
Figure Prostate Cancer Examples
Table Key Downstream Customer in Prostate Cancer
Figure Respiratory/Lung Cancer Examples
Table Key Downstream Customer in Respiratory/Lung Cancer
Figure Other Cancers Examples
Table Key Downstream Customer in Other Cancers
Figure Global Cancer Treatment Drugs Market Size (Million USD) by Regions (2013-2025)
Figure United States Cancer Treatment Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure Europe Cancer Treatment Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure China Cancer Treatment Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure Japan Cancer Treatment Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southeast Asia Cancer Treatment Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure India Cancer Treatment Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure Global Cancer Treatment Drugs Sales Volume (K Units) and Growth Rate (2013-2025)
Figure Global Cancer Treatment Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure Global Market Major Players Cancer Treatment Drugs Sales Volume (K Units) (2013-2018)
Table Global Cancer Treatment Drugs Sales (K Units) of Key Players/Suppliers (2013-2018)
Table Global Cancer Treatment Drugs Sales Share by Players/Suppliers (2013-2018)
Figure 2017 Cancer Treatment Drugs Sales Share by Players/Suppliers
Figure 2017 Cancer Treatment Drugs Sales Share by Players/Suppliers
Figure Global Cancer Treatment Drugs Revenue (Million USD) by Players/Suppliers (2013-2018)
Table Global Cancer Treatment Drugs Revenue (Million USD) by Players/Suppliers (2013-2018)
Table Global Cancer Treatment Drugs Revenue Share by Players/Suppliers (2013-2018)
Table 2017 Global Cancer Treatment Drugs Revenue Share by Players
Table 2017 Global Cancer Treatment Drugs Revenue Share by Players
Table Global Cancer Treatment Drugs Sales (K Units) and Market Share by Type (2013-2018)
Table Global Cancer Treatment Drugs Sales Share (K Units) by Type (2013-2018)
Figure Sales Market Share of Cancer Treatment Drugs by Type (2013-2018)
Figure Global Cancer Treatment Drugs Sales Growth Rate by Type (2013-2018)
Table Global Cancer Treatment Drugs Revenue (Million USD) and Market Share by Type (2013-2018)
Table Global Cancer Treatment Drugs Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Cancer Treatment Drugs by Type (2013-2018)
Figure Global Cancer Treatment Drugs Revenue Growth Rate by Type (2013-2018)
Table Global Cancer Treatment Drugs Sales Volume (K Units) and Market Share by Region (2013-2018)
Table Global Cancer Treatment Drugs Sales Share by Region (2013-2018)
Figure Sales Market Share of Cancer Treatment Drugs by Region (2013-2018)
Figure Global Cancer Treatment Drugs Sales Growth Rate by Region in 2017
Table Global Cancer Treatment Drugs Revenue (Million USD) and Market Share by Region (2013-2018)
Table Global Cancer Treatment Drugs Revenue Share (%) by Region (2013-2018)
Figure Revenue Market Share of Cancer Treatment Drugs by Region (2013-2018)
Figure Global Cancer Treatment Drugs Revenue Growth Rate by Region in 2017
Table Global Cancer Treatment Drugs Revenue (Million USD) and Market Share by Region (2013-2018)
Table Global Cancer Treatment Drugs Revenue Share (%) by Region (2013-2018)
Figure Revenue Market Share of Cancer Treatment Drugs by Region (2013-2018)
Figure Global Cancer Treatment Drugs Revenue Market Share by Region in 2017
Table Global Cancer Treatment Drugs Sales Volume (K Units) and Market Share by Application (2013-2018)
Table Global Cancer Treatment Drugs Sales Share (%) by Application (2013-2018)
Figure Sales Market Share of Cancer Treatment Drugs by Application (2013-2018)
Figure Global Cancer Treatment Drugs Sales Market Share by Application (2013-2018)
Figure United States Cancer Treatment Drugs Sales (K Units) and Growth Rate (2013-2018)
Figure United States Cancer Treatment Drugs Revenue (Million USD) and Growth Rate (2013-2018)
Figure United States Cancer Treatment Drugs Sales Price (USD/Unit) Trend (2013-2018)
Table United States Cancer Treatment Drugs Sales Volume (K Units) by Players (2013-2018)
Table United States Cancer Treatment Drugs Sales Volume Market Share by Players (2013-2018)
Figure United States Cancer Treatment Drugs Sales Volume Market Share by Players in 2017
Table United States Cancer Treatment Drugs Sales Volume (K Units) by Type (2013-2018)
Table United States Cancer Treatment Drugs Sales Volume Market Share by Type (2013-2018)
Figure United States Cancer Treatment Drugs Sales Volume Market Share by Type in 2017
Table United States Cancer Treatment Drugs Sales Volume (K Units) by Application (2013-2018)
Table United States Cancer Treatment Drugs Sales Volume Market Share by Application (2013-2018)
Figure United States Cancer Treatment Drugs Sales Volume Market Share by Application in 2017
Figure Europe Cancer Treatment Drugs Sales (K Units) and Growth Rate (2013-2018)
Figure Europe Cancer Treatment Drugs Revenue (Million USD) and Growth Rate (2013-2018)
Figure Europe Cancer Treatment Drugs Sales Price (USD/Unit) Trend (2013-2018)
Table Europe Cancer Treatment Drugs Sales Volume (K Units) by Players (2013-2018)
Table Europe Cancer Treatment Drugs Sales Volume Market Share by Players (2013-2018)
Figure Europe Cancer Treatment Drugs Sales Volume Market Share by Players in 2017
Table Europe Cancer Treatment Drugs Sales Volume (K Units) by Type (2013-2018)
Table Europe Cancer Treatment Drugs Sales Volume Market Share by Type (2013-2018)
Figure Europe Cancer Treatment Drugs Sales Volume Market Share by Type in 2017
Table Europe Cancer Treatment Drugs Sales Volume (K Units) by Application (2013-2018)
Table Europe Cancer Treatment Drugs Sales Volume Market Share by Application (2013-2018)
Figure Europe Cancer Treatment Drugs Sales Volume Market Share by Application in 2017
Figure China Cancer Treatment Drugs Sales (K Units) and Growth Rate (2013-2018)
Figure China Cancer Treatment Drugs Revenue (Million USD) and Growth Rate (2013-2018)
Figure China Cancer Treatment Drugs Sales Price (USD/Unit) Trend (2013-2018)
Table China Cancer Treatment Drugs Sales Volume (K Units) by Players (2013-2018)
Table China Cancer Treatment Drugs Sales Volume Market Share by Players (2013-2018)
Figure China Cancer Treatment Drugs Sales Volume Market Share by Players in 2017
Table China Cancer Treatment Drugs Sales Volume (K Units) by Type (2013-2018)
Table China Cancer Treatment Drugs Sales Volume Market Share by Type (2013-2018)
Figure China Cancer Treatment Drugs Sales Volume Market Share by Type in 2017
Table China Cancer Treatment Drugs Sales Volume (K Units) by Application (2013-2018)
Table China Cancer Treatment Drugs Sales Volume Market Share by Application (2013-2018)
Figure China Cancer Treatment Drugs Sales Volume Market Share by Application in 2017
Figure Japan Cancer Treatment Drugs Sales (K Units) and Growth Rate (2013-2018)
Figure Japan Cancer Treatment Drugs Revenue (Million USD) and Growth Rate (2013-2018)
Figure Japan Cancer Treatment Drugs Sales Price (USD/Unit) Trend (2013-2018)
Table Japan Cancer Treatment Drugs Sales Volume (K Units) by Players (2013-2018)
Table Japan Cancer Treatment Drugs Sales Volume Market Share by Players (2013-2018)
Figure Japan Cancer Treatment Drugs Sales Volume Market Share by Players in 2017
Table Japan Cancer Treatment Drugs Sales Volume (K Units) by Type (2013-2018)
Table Japan Cancer Treatment Drugs Sales Volume Market Share by Type (2013-2018)
Figure Japan Cancer Treatment Drugs Sales Volume Market Share by Type in 2017
Table Japan Cancer Treatment Drugs Sales Volume (K Units) by Application (2013-2018)
Table Japan Cancer Treatment Drugs Sales Volume Market Share by Application (2013-2018)
Figure Japan Cancer Treatment Drugs Sales Volume Market Share by Application in 2017
Figure Southeast Asia Cancer Treatment Drugs Sales (K Units) and Growth Rate (2013-2018)
Figure Southeast Asia Cancer Treatment Drugs Revenue (Million USD) and Growth Rate (2013-2018)
Figure Southeast Asia Cancer Treatment Drugs Sales Price (USD/Unit) Trend (2013-2018)
Table Southeast Asia Cancer Treatment Drugs Sales Volume (K Units) by Players (2013-2018)
Table Southeast Asia Cancer Treatment Drugs Sales Volume Market Share by Players (2013-2018)
Figure Southeast Asia Cancer Treatment Drugs Sales Volume Market Share by Players in 2017
Table Southeast Asia Cancer Treatment Drugs Sales Volume (K Units) by Type (2013-2018)
Table Southeast Asia Cancer Treatment Drugs Sales Volume Market Share by Type (2013-2018)
Figure Southeast Asia Cancer Treatment Drugs Sales Volume Market Share by Type in 2017
Table Southeast Asia Cancer Treatment Drugs Sales Volume (K Units) by Application (2013-2018)
Table Southeast Asia Cancer Treatment Drugs Sales Volume Market Share by Application (2013-2018)
Figure Southeast Asia Cancer Treatment Drugs Sales Volume Market Share by Application in 2017
Figure India Cancer Treatment Drugs Sales (K Units) and Growth Rate (2013-2018)
Figure India Cancer Treatment Drugs Revenue (Million USD) and Growth Rate (2013-2018)
Figure India Cancer Treatment Drugs Sales Price (USD/Unit) Trend (2013-2018)
Table India Cancer Treatment Drugs Sales Volume (K Units) by Players (2013-2018)
Table India Cancer Treatment Drugs Sales Volume Market Share by Players (2013-2018)
Figure India Cancer Treatment Drugs Sales Volume Market Share by Players in 2017
Table India Cancer Treatment Drugs Sales Volume (K Units) by Type (2013-2018)
Table India Cancer Treatment Drugs Sales Volume Market Share by Type (2013-2018)
Figure India Cancer Treatment Drugs Sales Volume Market Share by Type in 2017
Table India Cancer Treatment Drugs Sales Volume (K Units) by Application (2013-2018)
Table India Cancer Treatment Drugs Sales Volume Market Share by Application (2013-2018)
Figure India Cancer Treatment Drugs Sales Volume Market Share by Application in 2017
Table Roche Basic Information List
Table Roche Cancer Treatment Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Roche Cancer Treatment Drugs Sales Growth Rate (2013-2018)
Figure Roche Cancer Treatment Drugs Sales Global Market Share (2013-2018)
Figure Roche Cancer Treatment Drugs Revenue Global Market Share (2013-2018)
Table Novartis Basic Information List
Table Novartis Cancer Treatment Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Novartis Cancer Treatment Drugs Sales Growth Rate (2013-2018)
Figure Novartis Cancer Treatment Drugs Sales Global Market Share (2013-2018)
Figure Novartis Cancer Treatment Drugs Revenue Global Market Share (2013-2018)
Table Celgene Basic Information List
Table Celgene Cancer Treatment Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Celgene Cancer Treatment Drugs Sales Growth Rate (2013-2018)
Figure Celgene Cancer Treatment Drugs Sales Global Market Share (2013-2018
Figure Celgene Cancer Treatment Drugs Revenue Global Market Share (2013-2018)
Table Bristol-Myers Squibb Basic Information List
Table Bristol-Myers Squibb Cancer Treatment Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Bristol-Myers Squibb Cancer Treatment Drugs Sales Growth Rate (2013-2018)
Figure Bristol-Myers Squibb Cancer Treatment Drugs Sales Global Market Share (2013-2018)
Figure Bristol-Myers Squibb Cancer Treatment Drugs Revenue Global Market Share (2013-2018)
Table Amgen Basic Information List
Table Amgen Cancer Treatment Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Amgen Cancer Treatment Drugs Sales Growth Rate (2013-2018)
Figure Amgen Cancer Treatment Drugs Sales Global Market Share (2013-2018)
Figure Amgen Cancer Treatment Drugs Revenue Global Market Share (2013-2018)
Table Johnson & Johnson Basic Information List
Table Johnson & Johnson Cancer Treatment Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Johnson & Johnson Cancer Treatment Drugs Sales Growth Rate (2013-2018)
Figure Johnson & Johnson Cancer Treatment Drugs Sales Global Market Share (2013-2018
Figure Johnson & Johnson Cancer Treatment Drugs Revenue Global Market Share (2013-2018)
Table Pfizer Basic Information List
Table Pfizer Cancer Treatment Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Pfizer Cancer Treatment Drugs Sales Growth Rate (2013-2018)
Figure Pfizer Cancer Treatment Drugs Sales Global Market Share (2013-2018)
Figure Pfizer Cancer Treatment Drugs Revenue Global Market Share (2013-2018)
Table Takeda Basic Information List
Table Takeda Cancer Treatment Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Takeda Cancer Treatment Drugs Sales Growth Rate (2013-2018)
Figure Takeda Cancer Treatment Drugs Sales Global Market Share (2013-2018
Figure Takeda Cancer Treatment Drugs Revenue Global Market Share (2013-2018)
Table Eli Lilly Basic Information List
Table Eli Lilly Cancer Treatment Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Eli Lilly Cancer Treatment Drugs Sales Growth Rate (2013-2018)
Figure Eli Lilly Cancer Treatment Drugs Sales Global Market Share (2013-2018)
Figure Eli Lilly Cancer Treatment Drugs Revenue Global Market Share (2013-2018)
Table AstraZeneca Basic Information List
Table AstraZeneca Cancer Treatment Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure AstraZeneca Cancer Treatment Drugs Sales Growth Rate (2013-2018)
Figure AstraZeneca Cancer Treatment Drugs Sales Global Market Share (2013-2018)
Figure AstraZeneca Cancer Treatment Drugs Revenue Global Market Share (2013-2018)
Table Astellas Basic Information List
Table Merck & Co. Basic Information List
Table Sanofi Basic Information List
Table Bayer Basic Information List
Table Biogen Idec Basic Information List
Table Eisai Basic Information List
Table Teva Basic Information List
Table Otsuka Basic Information List
Table Merck KGaA Basic Information List
Table Ipsen Basic Information List
Table AbbVie Basic Information List
Table Gilead Sciences Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Cancer Treatment Drugs
Figure Manufacturing Process Analysis of Cancer Treatment Drugs
Figure Cancer Treatment Drugs Industrial Chain Analysis
Table Raw Materials Sources of Cancer Treatment Drugs Major Players in 2017
Table Major Buyers of Cancer Treatment Drugs
Table Distributors/Traders List
Figure Global Cancer Treatment Drugs Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure Global Cancer Treatment Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Global Cancer Treatment Drugs Price (USD/Unit) and Trend Forecast (2018-2025)
Table Global Cancer Treatment Drugs Sales Volume (K Units) Forecast by Regions (2018-2025)
Figure Global Cancer Treatment Drugs Sales Volume Market Share Forecast by Regions (2018-2025)
Figure Global Cancer Treatment Drugs Sales Volume Market Share Forecast by Regions in 2025
Table Global Cancer Treatment Drugs Revenue (Million USD) Forecast by Regions (2018-2025)
Figure Global Cancer Treatment Drugs Revenue Market Share Forecast by Regions (2018-2025)
Figure Global Cancer Treatment Drugs Revenue Market Share Forecast by Regions in 2025
Figure United States Cancer Treatment Drugs Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure United States Cancer Treatment Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Europe Cancer Treatment Drugs Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure Europe Cancer Treatment Drugs Revenue and Growth Rate Forecast (2018-2025)
Figure China Cancer Treatment Drugs Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure China Cancer Treatment Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Japan Cancer Treatment Drugs Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure Japan Cancer Treatment Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Cancer Treatment Drugs Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Cancer Treatment Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure India Cancer Treatment Drugs Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure India Cancer Treatment Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Global Cancer Treatment Drugs Sales (K Units) Forecast by Type (2018-2025)
Figure Global Cancer Treatment Drugs Sales Volume Market Share Forecast by Type (2018-2025)
Table Global Cancer Treatment Drugs Revenue (Million USD) Forecast by Type (2018-2025)
Figure Global Cancer Treatment Drugs Revenue Market Share Forecast by Type (2018-2025)
Table Global Cancer Treatment Drugs Price (USD/Unit) Forecast by Type (2018-2025)
Table Global Cancer Treatment Drugs Sales (K Units) Forecast by Application (2018-2025)
Figure Global Cancer Treatment Drugs Sales Market Share Forecast by Application (2018-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【レポートのキーワード】

がん治療薬、化学療法、標的療法、免疫療法、ホルモン療法(生物療法)、血液がん、乳がん、胃腸がん、前立腺がん、呼吸器系がん・肺がん

【免責事項】
※当レポート上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当レポートに記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当レポート上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチはその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチが翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。

[がん治療薬の世界市場:販売動向2018] (Global Cancer Treatment Drugs Sales Market Report 2018 / QYR80702920)についてメールでお問い合わせはこちら


◆H&Iグローバルリサーチ株式会社のお客様(例)◆